CRISPR Therapeutics AG - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
CRISPR Therapeutics AG (CRISPR Therapeutics) is a gene editing company. It utilizes its proprietary technology, CRISPR (Clustered, Regularly Interspaced Short Palindromic Repeats)/Cas9 (CRISPR-associated protein-9), to precisely alter specific sequences of genomic deoxyribonucleic acid (DNA). The company's products are primarily used in the healthcare industry, specifically in the treatment and prevention of both rare and common diseases. Its portfolio includes multiple therapeutic programs in areas such as hemoglobinopathies, immuno-oncology, autoimmune diseases, and type 1 diabetes. The company's advanced program, Casgevy, is approved for treating severe sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT). CRISPR Therapeutics is headquartered in Zug, Switzerland.Scope
- Detailed information on CRISPR Therapeutics AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting CRISPR Therapeutics AG in the form of a SWOT analysis
- An in-depth view of the business model of CRISPR Therapeutics AG including a breakdown and examination of key business segments
- Intelligence on CRISPR Therapeutics AG's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about CRISPR Therapeutics AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of CRISPR Therapeutics AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess CRISPR Therapeutics AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on CRISPR Therapeutics AG's business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- CRISPR Therapeutics AG: Company Overview
- CRISPR Therapeutics AG: Overview and Key Facts
- CRISPR Therapeutics AG: Overview
- CRISPR Therapeutics AG: Key Facts
- CRISPR Therapeutics AG: Key Employees
- CRISPR Therapeutics AG: Key Employee Biographies
- CRISPR Therapeutics AG: Major Products and Services
- CRISPR Therapeutics AG: Company History
- CRISPR Therapeutics AG: Management Statement
- CRISPR Therapeutics AG: Locations and Subsidiaries
- CRISPR Therapeutics AG: Key Competitors
- CRISPR Therapeutics AG: Company Analysis
- CRISPR Therapeutics AG: Business Description
- CRISPR Therapeutics AG: SWOT Analysis
- CRISPR Therapeutics AG: SWOT Overview
- CRISPR Therapeutics AG: Strengths
- CRISPR Therapeutics AG: Weaknesses
- CRISPR Therapeutics AG: Opportunities
- CRISPR Therapeutics AG: Threats
- CRISPR Therapeutics AG: Corporate Financial Deals Activity
- CRISPR Therapeutics AG: Financial Deals Overview
- CRISPR Therapeutics AG: Targets and Partners
- CRISPR Therapeutics AG: Top Deals 2020 - 2024YTD*
- CRISPR Therapeutics AG: Advisors
- CRISPR Therapeutics AG: Top Legal Advisors
- CRISPR Therapeutics AG: Top Financial Advisors
- CRISPR Therapeutics AG: Corporate Venturing
- CRISPR Therapeutics AG: Capital Raising
- CRISPR Therapeutics AG: Partnership
- CRISPR Therapeutics AG: Recent Developments
- CRISPR Therapeutics AG: News and Events Summary
- CRISPR Therapeutics AG: Corporate Governance
- CRISPR Therapeutics AG: Financial Performance
- CRISPR Therapeutics AG: Grants
- CRISPR Therapeutics AG: Market Developments
- CRISPR Therapeutics AG: Regulatory and Legal Events
- CRISPR Therapeutics AG: Research & Development
- CRISPR Therapeutics AG: Strategy and Operations
- Appendix
- Contact the Publisher
- Methodology
- About the Publisher
Table 1: CRISPR Therapeutics AG: Key Facts
Table 2: CRISPR Therapeutics AG: Key Employees
Table 3: CRISPR Therapeutics AG: Company History
Table 4: CRISPR Therapeutics AG: Locations and Subsidiaries
Table 5: CRISPR Therapeutics AG: Key Competitors
Table 6: CRISPR Therapeutics AG: Deal Activity by Deal Type - Volume (TTM*)
Table 7: CRISPR Therapeutics AG: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Table 8: CRISPR Therapeutics AG: Targets and Partners
Table 9: CRISPR Therapeutics AG: Top Deals 2020 - 2024YTD*
Table 10: CRISPR Therapeutics AG: Legal Advisor Ranking by Value (US$m)
Table 11: CRISPR Therapeutics AG: Financial Advisor Ranking by Value (US$m)
Table 12: CRISPR Therapeutics AG: Corporate Venturing Volume and Value Trend (2020 - YTD*2024)
Table 13: CRISPR Therapeutics AG: Corporate Venturing by Geography (2020 - YTD*2024)
Table 14: CRISPR Therapeutics AG: Capital Raising Volume and Value Trend (2020 - YTD*2024)
Table 15: CRISPR Therapeutics AG: Capital Raising by Deal Type (2020 - YTD*2024)
Table 16: CRISPR Therapeutics AG: Partnership Volume and Value Trend (2020 - YTD*2024)
Table 17: CRISPR Therapeutics AG: Partnership Trend by Deal Type (2020 - YTD*2024)
Table 18: CRISPR Therapeutics AG: News and Events Summary
Table 19: CRISPR Therapeutics AG: Corporate Governance
Table 20: CRISPR Therapeutics AG: Financial Performance
Table 21: CRISPR Therapeutics AG: Grants
Table 22: CRISPR Therapeutics AG: Market Developments
Table 23: CRISPR Therapeutics AG: Regulatory and Legal Events
Table 24: CRISPR Therapeutics AG: Research & Development
Table 25: CRISPR Therapeutics AG: Strategy and Operations
List of Figures
Figure 1: CRISPR Therapeutics AG: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: CRISPR Therapeutics AG: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Figure 3: CRISPR Therapeutics AG: Corporate Venturing Volume and Value Trend (2020 - YTD*2024)
Figure 4: CRISPR Therapeutics AG: Corporate Venturing by Geography (2020 - YTD*2024)
Figure 5: CRISPR Therapeutics AG: Capital Raising Volume and Value Trend (2020 - YTD*2024)
Figure 6: CRISPR Therapeutics AG: Capital Raising by Deal Type (2020 - YTD*2024)
Figure 7: CRISPR Therapeutics AG: Partnership Volume and Value Trend (2020 - YTD*2024)
Figure 8: CRISPR Therapeutics AG: Partnership Trend by Deal Type (2020 - YTD*2024)
